Aptevo Therapeutics's total assets for Q1 2025 were $8.34M, a decrease of -46.49% from the previous quarter. APVO total liabilities were $9.81M for the fiscal quarter, a -9.42% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.